These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 30252904)

  • 1. Are death and loss to follow-up still high in people living with HIV on ART after national scale-up and earlier treatment initiation? A large cohort study in government hospital-based setting, Myanmar: 2013-2016.
    Aung ZZ; Oo MM; Tripathy JP; Kyaw NTT; Hone S; Oo HN; Majumdar SS
    PLoS One; 2018; 13(9):e0204550. PubMed ID: 30252904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retention and risk factors for attrition in a large public health ART program in Myanmar: a retrospective cohort analysis.
    Thida A; Tun ST; Zaw SK; Lover AA; Cavailler P; Chunn J; Aye MM; Par P; Naing KW; Zan KN; Shwe M; Kyaw TT; Waing ZH; Clevenbergh P
    PLoS One; 2014; 9(9):e108615. PubMed ID: 25268903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with attrition, mortality, and loss to follow up after antiretroviral therapy initiation: data from an HIV cohort study in India.
    Alvarez-Uria G; Naik PK; Pakam R; Midde M
    Glob Health Action; 2013 Sep; 6():21682. PubMed ID: 24028937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with death and loss to follow-up in children on antiretroviral care in Mingalardon Specialist Hospital, Myanmar, 2006-2016.
    Kaung Nyunt KK; Han WW; Satyanarayana S; Isaakidis P; Hone S; Khaing AA; Nguyen Binh H; Oo HN
    PLoS One; 2018; 13(4):e0195435. PubMed ID: 29621302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attrition among HIV positive children enrolled under integrated HIV care programme in Myanmar: 12 years cohort analysis.
    Minn AC; Kyaw NTT; Aung TK; Mon OM; Htun T; Oo MM; Moe J; Mon AA; Satyanarayana S; Oo HN
    Glob Health Action; 2018; 11(1):1510593. PubMed ID: 30191749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retention and mortality outcomes from a community-supported public-private HIV treatment programme in Myanmar.
    Mburu G; Paing AZ; Myint NN; Di W; Thu KH; Ram M; Hoffmann CJ; Wang B; Naing S
    J Int AIDS Soc; 2016; 19(1):20926. PubMed ID: 27784509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment outcomes from the largest antiretroviral treatment program in Myanmar (Burma): a cohort analysis of retention after scale-up.
    Sabapathy K; Ford N; Chan KN; Kyaw MK; Elema R; Smithuis F; Floyd S
    J Acquir Immune Defic Syndr; 2012 Jun; 60(2):e53-62. PubMed ID: 22334069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with long-term antiretroviral therapy attrition among adolescents in rural Uganda: a retrospective study.
    Okoboi S; Ssali L; Yansaneh AI; Bakanda C; Birungi J; Nantume S; Okullu JL; Sharp AR; Moore DM; Kalibala S
    J Int AIDS Soc; 2016; 19(5 Suppl 4):20841. PubMed ID: 27443271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High attrition among HIV-infected patients with advanced disease treated in an intermediary referral center in Maputo, Mozambique.
    Molfino L; Kumar AM; Isaakidis P; Van den Bergh R; Khogali M; Hinderaker SG; Magaia A; Lobo S; Edwards CG; Walter J
    Glob Health Action; 2014; 7():23758. PubMed ID: 24717189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High rates of loss to follow-up during the first year of pre-antiretroviral therapy for HIV patients at sites providing pre-ART care in Nigeria, 2004-2012.
    Agolory SG; Auld AF; Odafe S; Shiraishi RW; Dokubo EK; Swaminathan M; Dalhatu I; Onotu D; Abiri O; Debem H; Bashorun A; Ellerbrock TV
    PLoS One; 2017; 12(9):e0183823. PubMed ID: 28863160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validity of reported retention in antiretroviral therapy after roll-out to peripheral facilities in Mozambique: Results of a retrospective national cohort analysis.
    Lafort Y; Couto A; Sunderbrink U; Hoek R; Shargie E; Zhao J; Viisainen K; Simwaka B
    PLoS One; 2018; 13(6):e0198916. PubMed ID: 29927961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persons living with HIV with advanced HIV disease: need for novel care models.
    Teasdale CA; Yuengling K; Preko P; Syowai M; Ndagije F; Rabkin M; Abrams EJ; El-Sadr WM
    J Int AIDS Soc; 2018 Dec; 21(12):e25210. PubMed ID: 30549245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expansion and scale-up of HIV care and treatment services in four countries over ten years.
    Teasdale CA; Abrams EJ; Yuengling KA; Lamb MR; Wang C; Vitale M; Hawken M; Melaku Z; Nuwagaba-Biribonwoha H; El-Sadr WM
    PLoS One; 2020; 15(4):e0231667. PubMed ID: 32298331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of Nigeria's HIV/AIDS Treatment Program for Patients Initiated on Antiretroviral Treatment between 2004-2012.
    Dalhatu I; Onotu D; Odafe S; Abiri O; Debem H; Agolory S; Shiraishi RW; Auld AF; Swaminathan M; Dokubo K; Ngige E; Asadu C; Abatta E; Ellerbrock TV
    PLoS One; 2016; 11(11):e0165528. PubMed ID: 27829033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of loss to follow-up among HIV positive patients receiving antiretroviral therapy in a test and treat setting: A retrospective cohort study in Masaka, Uganda.
    Kiwanuka J; Mukulu Waila J; Muhindo Kahungu M; Kitonsa J; Kiwanuka N
    PLoS One; 2020; 15(4):e0217606. PubMed ID: 32255796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid antiretroviral initiation among Thai youth living with HIV in the National AIDS programme in the era of treatment at any CD4 cell count: a national registry database study.
    Teeraananchai S; Kerr SJ; Khananuraksa P; Ruxrungtham K; Puthanakit T
    J Int AIDS Soc; 2020 Sep; 23 Suppl 5(Suppl 5):e25574. PubMed ID: 32869537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time to anti-retroviral therapy among people living with HIV enrolled into care in Myanmar: how prepared are we for 'test and treat'?
    Linn KZ; Shewade HD; Htet KKK; Maung TM; Hone S; Oo HN
    Glob Health Action; 2018; 11(1):1520473. PubMed ID: 30499382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV care in Yangon, Myanmar; successes, challenges and implications for policy.
    Aung NM; Hanson J; Kyi TT; Htet ZW; Cooper DA; Boyd MA; Kyi MM; Saw HA
    AIDS Res Ther; 2017 Mar; 14(1):10. PubMed ID: 28257647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics and early clinical outcomes of key populations attending comprehensive community-based HIV care: Experiences from Nasarawa State, Nigeria.
    Ibiloye O; Decroo T; Eyona N; Eze P; Agada P
    PLoS One; 2018; 13(12):e0209477. PubMed ID: 30571744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal trends in mortality and loss to follow-up among children enrolled in Côte d'Ivoire's national antiretroviral therapy program.
    Auld AF; Tuho MZ; Ekra KA; Shiraishi RW; Mohamed F; Kouakou JS; Ettiègne-Traoré V; Sabatier J; Essombo J; Rivadeneira ED; Adjorlolo-Johnson G; Marlink R; Ellerbrock TV
    Pediatr Infect Dis J; 2014 Nov; 33(11):1134-40. PubMed ID: 25093975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.